Drug Discovery and Development
The pharmaceutical sector, a foundation of the healthcare sector,
is undergoing extensive change, essentially caused by lower output of new
medicines from research and development (R&D) laboratories, drug pricing pressures, stricter regulatory environments and
the overall current economic recession. This sorts strains of all
pharmaceutical firms to find better ways to raise their yield of new drugs, complete
improvement, to equally treat patients and happen their shareholders assumption.